Pharmaceutical Commerce

Go in-between the pages and behind the scenes of Pharmaceutical Commerce Magazine

Episodes

Pharma Pulse: FDA Clears First Oral Wegovy; Yusen Logistics Seals European Health Deal

December 24, 2025 • 1 min

In today’s Pharma Pulse, Novo Nordisk secures a landmark approval for a weight-loss pill, while Yusen Logistics expands its end-to-end supply chain capabilities across Europe.

Mark as Played

Pharma Pulse: US Manufacturing Expansion, Oncology Partnerships, and Workplace Health

December 23, 2025 • 2 mins

In today’s Pharma Pulse, Samsung Biologics enters the US market with a $280 million site acquisition, AstraZeneca secures a multi-billion-dollar cancer deal, and new research identifies occupational drivers of long COVID.

Mark as Played

Pharma Pulse: TrumpRx Gains Nine New Pharma Partners; DHL Expands LAX Cold Chain Hub

December 22, 2025 • 1 min

In today’s Pharma Pulse, major pharma players commit to most-favored-nation pricing, as DHL bolsters West Coast logistics for temperature-sensitive drugs.

Mark as Played

Pharma Pulse: Navigating the Biosecure Act, Post-Viral Sleep Phenotypes, and Rising Insurance Costs

December 19, 2025 • 2 mins

In today’s Pharma Pulse, the Senate advances legislation to block "biotechnology companies of concern," clinical research ties COVID-19 to REM-dominant sleep apnea, and a new analysis reveals an affordability breaking point for employer-sponsored health insurance.

Mark as Played

Pharma Pulse: The ACA Subsidy Cliff and New Frontiers for GLP-1s

December 18, 2025 • 2 mins

In today’s Pharma Pulse, House Republicans block a critical insurance subsidy extension, as new research highlights the oncology benefits of GLP-1s.

Mark as Played

Pharma Pulse: Onshoring Investments and the AI Frontier

December 17, 2025 • 2 mins

In today’s Pharma Pulse, Novartis and Moderna anchor a domestic manufacturing surge, while AI-driven biomarker discovery and physician well-being reshape the future of clinical care.

Mark as Played

Pharma Pulse: SOBI’s $1.5B Gout Acquisition Clears Pipeline; New Cholesterol Drug Lerochol Scores on Convenience

December 16, 2025 • 2 mins

In today’s Pharma Pulse, SOBI strengthens its gout franchise by acquiring Arthrosi Therapeutics for up to $1.5 billion, securing the Phase III asset pozdeutinurad, and much more.

Mark as Played

Pharma Pulse: Amgen's Uplizna Secures CD19 Approval for Myasthenia Gravis, as Asthma Biologic Switches Highlight Efficacy Expectations Gap

December 15, 2025 • 2 mins

In today’s Pharma Pulse, the FDA approves Amgen’s Uplizna (inebilizumab-cdon), the first CD19-targeted therapy for gMG with convenient twice-yearly dosing, and much more.

Mark as Played

Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial

December 12, 2025 • 2 mins

In today’s Pharma Pulse, the Senate fails to advance bills extending enhanced ACA subsidies, leaving 22 million enrollees facing sharp premium increases, and much more.

Mark as Played

Pharma Pulse: FDA Fast-Tracks Antibiotic Approval, as Protected EHR Time Combats Physician Burnout

December 11, 2025 • 1 min

In today’s Pharma Pulse, Augmentin XR is the first drug approved under the FDA's new CNPV pilot program and much more.

Mark as Played

Pharma Pulse: FDA Shifts CAR-T Standards and Maryland Expands Medical Class Size, as Pharma Channels Brace for Massive Patent Cliff Disruption

December 10, 2025 • 2 mins

In today’s Pharma Pulse, the University of Maryland expands its medical class to combat physician shortages and much more.

Mark as Played

Pharma Pulse: Lilly’s Jaypirca Challenges Imbruvica, as AI Chatbots Could Prove Key to Boosting Vaccine Rates

December 9, 2025 • 2 mins

In today’s Pharma Pulse, new trials confirm AI chatbots are a successful and sustainable tool for increasing pneumococcal vaccine uptake among older adults and much more.

Mark as Played

Pharma Pulse: ACIP Ends Universal Hep B Birth Dose

December 8, 2025 • 2 mins

In today’s Pharma Pulse, the ACIP votes to end the decades-long universal hepatitis B birth dose recommendation; meanwhile, former FDA commissioners warn that new vaccine policies are compromising the long-standing regulatory framework and jeopardizing public health security.

Mark as Played

Pharma Pulse: New CDER Director Appointed, as Medicaid Shows Potential to Save Cancer Lives

December 5, 2025 • 2 mins

In today’s Pharma Pulse, Dr. Tracy Beth Høeg is named acting CDER director amidst high leadership turnover, promising modernization and transparency.

Mark as Played

Pharma Pulse: Pazdur Retires from FDA, While Public Trusts AMA Over CDC on Vaccines, and New Data Redefines Adherence as an Emotional Crisis

December 4, 2025 • 2 mins

In today’s Pharma Pulse, Dr. Richard Pazdur retires from his CDER director role weeks after his appointment, and much more.

Mark as Played

Pharma Pulse: Long COVID Exercise Win, $150M Gene Editing Play, and Compounding Pharmacy Expansions

December 3, 2025 • 2 mins

In today’s Pharma Pulse, a structured exercise program is proven to manage persistent long COVID symptoms, while Regeneron commits $150 million upfront to Tessera for a gene writing therapy targeting AATD, and Strive Pharmacy invests in a massive Arizona facility to boost national personalized medicine capacity.

Mark as Played

Pharma Pulse: US-UK Trade Deal Forces Pricing Shift, as Lilly Deepens GLP-1 Price Cuts and RSV-Asthma Link Confirmed

December 2, 2025 • 1 min

In today’s Pharma Pulse, a US-UK trade agreement mandates that the UK’s NICE agency raises its QALY threshold, increasing access to innovative drugs, and much more.

Mark as Played

Pharma Pulse: Medicare Price Cuts and Vaccine Wins

December 1, 2025 • 2 mins

From billions in drug savings and more, we present to you today’s Pharma Pulse.

Mark as Played

Pharma Pulse: Medicare Price Negotiations Heat Up, as FDA Approves SMA Gene Therapy

November 26, 2025 • 2 mins

In today’s Pharma Pulse, the federal government prepares to unveil newly negotiated Medicare prices for 15 high-cost drugs, while Novartis receives FDA approval for Itvisma, a one-time gene therapy offering a new treatment pathway for older children and adults with spinal muscular atrophy.

Mark as Played

Pharma Pulse: RSV Protection Wanes, AstraZeneca Invests Big, and Novo Nordisk Faces Pipeline Setback

November 25, 2025 • 2 mins

A new Pharma Pulse unpacks declining RSV vaccine durability in older adults, AstraZeneca’s $2 billion expansion of its US biologics manufacturing footprint, and the stock-shaking Phase III struggle affecting Novo Nordisk’s Alzheimer’s ambitions.

Mark as Played

Popular Podcasts

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

The Bobby Bones Show

Listen to 'The Bobby Bones Show' by downloading the daily full replay.

The Joe Rogan Experience

The official podcast of comedian Joe Rogan.

Betrayal: Weekly

Betrayal Weekly is back for a brand new season. Every Thursday, Betrayal Weekly shares first-hand accounts of broken trust, shocking deceptions, and the trail of destruction they leave behind. Hosted by Andrea Gunning, this weekly ongoing series digs into real-life stories of betrayal and the aftermath. From stories of double lives to dark discoveries, these are cautionary tales and accounts of resilience against all odds. From the producers of the critically acclaimed Betrayal series, Betrayal Weekly drops new episodes every Thursday. Please join our Substack for additional exclusive content, curated book recommendations and community discussions. Sign up FREE by clicking this link Beyond Betrayal Substack. Join our community dedicated to truth, resilience and healing. Your voice matters! Be a part of our Betrayal journey on Substack. And make sure to check out Seasons 1-4 of Betrayal, along with Betrayal Weekly Season 1.

Advertise With Us

Pharmaceutical Commerce

Episodes

.css-14f5ked{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:2;overflow:hidden;}Pharma Pulse: FDA Clears First Oral Wegovy; Yusen Logistics Seals European Health Deal

.css-r6mb8g{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:1;overflow:hidden;}Pharma Pulse: US Manufacturing Expansion, Oncology Partnerships, and Workplace Health

Pharma Pulse: TrumpRx Gains Nine New Pharma Partners; DHL Expands LAX Cold Chain Hub

Pharma Pulse: Navigating the Biosecure Act, Post-Viral Sleep Phenotypes, and Rising Insurance Costs

Pharma Pulse: The ACA Subsidy Cliff and New Frontiers for GLP-1s

Pharma Pulse: Onshoring Investments and the AI Frontier

Pharma Pulse: SOBI’s $1.5B Gout Acquisition Clears Pipeline; New Cholesterol Drug Lerochol Scores on Convenience

Pharma Pulse: Amgen's Uplizna Secures CD19 Approval for Myasthenia Gravis, as Asthma Biologic Switches Highlight Efficacy Expectations Gap

Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial

Pharma Pulse: FDA Fast-Tracks Antibiotic Approval, as Protected EHR Time Combats Physician Burnout

Pharma Pulse: FDA Shifts CAR-T Standards and Maryland Expands Medical Class Size, as Pharma Channels Brace for Massive Patent Cliff Disruption

Pharma Pulse: Lilly’s Jaypirca Challenges Imbruvica, as AI Chatbots Could Prove Key to Boosting Vaccine Rates

Pharma Pulse: ACIP Ends Universal Hep B Birth Dose

Pharma Pulse: New CDER Director Appointed, as Medicaid Shows Potential to Save Cancer Lives

Pharma Pulse: Pazdur Retires from FDA, While Public Trusts AMA Over CDC on Vaccines, and New Data Redefines Adherence as an Emotional Crisis

Pharma Pulse: Long COVID Exercise Win, $150M Gene Editing Play, and Compounding Pharmacy Expansions

Pharma Pulse: US-UK Trade Deal Forces Pricing Shift, as Lilly Deepens GLP-1 Price Cuts and RSV-Asthma Link Confirmed

Pharma Pulse: Medicare Price Cuts and Vaccine Wins

Pharma Pulse: Medicare Price Negotiations Heat Up, as FDA Approves SMA Gene Therapy

Pharma Pulse: RSV Protection Wanes, AstraZeneca Invests Big, and Novo Nordisk Faces Pipeline Setback

Popular Podcasts

Pharma Pulse: FDA Clears First Oral Wegovy; Yusen Logistics Seals European Health Deal

Pharma Pulse: US Manufacturing Expansion, Oncology Partnerships, and Workplace Health